Skip to Content

AN 794 (Imatinib Mesylate 100 mg)

Pill with imprint AN 794 is Brown, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Amneal Pharmaceuticals LLC.

Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AN 794

Imatinib mesylate 100 mg AN 794

Imatinib Mesylate

Imprint
AN 794
Strength
100 mg
Color
Brown
Shape
Round
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals LLC
National Drug Code (NDC)
65162-0794

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.